EMVision Medical Devices Ltd Share Price OTC Markets
Stocks
EMVDF
AU0000028375
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 07-15 | EMVision Prepares to Add Acute Ischemia Detection Endpoint to Brain Scanner Validation Trial; Shares Up 8% | MT |
| 05-25 | Emvision Medical Devices to receive A$1.17m igp grant instalment | RE |
| Market Cap | 151M 105M 91.89M 84.8M 78.16M 147M 10.13B 1.01B 399M 4.96B 395M 386M 17.07B | P/E 2026 * |
-16.5x | P/E 2027 * | -14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 151M 105M 91.89M 84.8M 78.16M 147M 10.13B 1.01B 399M 4.96B 395M 386M 17.07B | EV / Sales 2026 * |
27.4x | EV / Sales 2027 * | 30.1x |
| Free-Float |
66.78% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Kirkland
CEO | Chief Executive Officer | - | 30/06/2023 |
Karl Pechmann
DFI | Director of Finance/CFO | - | 31/01/2026 |
Forough Khandan
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
John Keep
CHM | Chairman | - | - |
Scott Kirkland
BRD | Director/Board Member | - | - |
Anthony Keane
BRD | Director/Board Member | - | 30/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 105M | ||
| -1.97% | +1.03% | +28.39% | -0.57% | 198B | ||
| -0.58% | +2.40% | +7.25% | -16.42% | 144B | ||
| -14.15% | -15.08% | -33.40% | -1.22% | 122B | ||
| -1.32% | -1.65% | -57.52% | -15.88% | 65.44B | ||
| -2.40% | -7.03% | +12.08% | -6.43% | 49.36B | ||
| +1.00% | -0.17% | -22.49% | -30.85% | 44.74B | ||
| -3.41% | -2.11% | +15.33% | +6.81% | 37.13B | ||
| -2.44% | -1.98% | +28.33% | +31.74% | 36.23B | ||
| -1.86% | -2.39% | -22.85% | -8.74% | 28.7B | ||
| Average | -0.78% | -2.81% | -4.99% | -4.62% | 80.68B | |
| Weighted average by Cap. | -0.48% | -2.62% | -0.90% | -5.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.5M 3.84M 3.36M 3.1M 2.85M 5.38M 370M 37.02M 14.56M 181M 14.42M 14.11M 624M | 5M 3.49M 3.05M 2.82M 2.6M 4.89M 336M 33.65M 13.24M 165M 13.11M 12.82M 567M |
| Net income | -9.1M -6.35M -5.55M -5.12M -4.72M -8.9M -612M -61.25M -24.09M -300M -23.86M -23.34M -1.03B | -12M -8.38M -7.32M -6.76M -6.23M -11.74M -807M -80.77M -31.77M -395M -31.47M -30.78M -1.36B |
| Net Debt | - | - |
Employees
-
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.620AUD
Average target price
3.150AUD
Spread / Average Target
+94.44%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- EMV Stock
- EMVDF Stock
Select your edition
All financial news and data tailored to specific country editions
















